Key facts
- This page summarizes Squadron Capital LLC's Form 4 filing for ORTHOPEDIATRICS CORP (KIDS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Sep 2022, 07:34.
Squadron Capital LLC - 20 Sep 2022 Form 4 Insider Report for ORTHOPEDIATRICS CORP (KIDS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- KIDS
- Reported as of
- 20 Sep 2022
- Net transaction value
- +$458
- SEC form
- 4
- Accepted by SEC
- 22 Sep 2022, 07:34:16 UTC
- Prior SEC filing
- 15 Aug 2022
- Next SEC filing
- 14 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ David R. Pelizzon, President of Squadron Capital LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Squadron Capital LLC filed Form 4 for ORTHOPEDIATRICS CORP (KIDS) on 22 Sep 2022.
Change
- Previous filing in this sequence was filed on 15 Aug 2022.
- Current net transaction value: +$458.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KIDS
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $458
- Shares
- +1,525,000
- Change %
- +28%
- Price
- $0.000300*
- Shares after
- 6,901,764
- Date
- 20 Sep 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KIDS
transaction
Derivative
Warrants (right to buy)
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- +1,525,000
- Change %
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,525,000
- Exercise price
- $0.000300
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.
Footnote F2
These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.